Hamann Svenningsen

  • Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various solid tumors, but only a small subgroup of patients benefit from them because of immune resistance. Oncorine (formerly H101), a recombinant human adenovirus type 5, has direct anticancer properties and enhances cell-mediated immune responses. At present, few studies on…[Read more]

  • Hamann Svenningsen became a registered member 11 hours, 54 minutes ago